Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Analysis File of Drug-Induced Lung Injury : Expert Opinion for Analysis of Big Data / / by Akihiko Gemma
| Analysis File of Drug-Induced Lung Injury : Expert Opinion for Analysis of Big Data / / by Akihiko Gemma |
| Autore | Gemma Akihiko |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (122 pages) |
| Disciplina | 616.2 |
| Soggetto topico |
Respiratory organs - Diseases
Medical genetics Diseases - Causes and theories of causation Oncology Pharmacology Genetics - Research Pneumology Clinical Genetics Pathogenesis Genetics Research |
| ISBN |
9789819734467
9789819734450 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I Understanding Drug-Induced Lung Injuries -- 1 Understanding Drug-Induced Lung Injuries -- Part 2 Actual Practice in Drug-Induced Lung Injuries of Each Drug -- 2 EGFR inhibitors (gefitinib, erlotinib, afatinib, osimertinib) -- 3 Anti-EGFR antibodies (cetuximab, panitumumab, necitumumab) -- 4 mTOR inhibitors (temsirolimus, everolimus) -- 5 Proteasome inhibitor (bortezomib) -- 6 Immune checkpoint inhibitors (nivolumab, pembrolizumab, atezolizumab, durvalumab) -- 7 Neoangiogenesis inhibitors (sunitinib, sorafenib, bevacizumab) -- 8 Other molecular targeted drugs (crizotinib, alectinib, etc.) -- 9 Antibody-drug conjugates (ADC) (trastuzumab emtansine, trastuzumab deruxtecan) -- 10 Anti-cancer drugs (TS-1, taxanes, CPT-11, platinum-containing drugs, etc.). |
| Record Nr. | UNINA-9910878983003321 |
Gemma Akihiko
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products / / edited by Jen-Tsung Chen
| Ethnopharmacology and Drug Discovery for COVID-19: Anti-SARS-CoV-2 Agents from Herbal Medicines and Natural Products / / edited by Jen-Tsung Chen |
| Autore | Chen Jen-Tsung |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (591 pages) |
| Disciplina | 614.5924144 |
| Soggetto topico |
Pharmacology
Natural products Nanobiotechnology Bioinformatics Diseases - Causes and theories of causation Molecular biology Natural Products Pathogenesis Molecular Biology |
| ISBN | 981-9936-64-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. COVID-19: An overview of virology, mutations, pathology, epidemiology, diagnosis, preventions and treatments -- 2. The recent development of therapeutic strategies against COVID-19 -- 3. Plant immunoenhancers: Promising ethnopharmacological candidates for anti-SARS-CoV-2 activity -- 4. Herbal formulations in fighting against the SARS-CoV-2 infection -- 5. Rejuvenation of traditional medicine in the 21st century against SARS-CoV-2 -- 6. Traditional herbal medicines and their active constituents in combating SARS-CoV-2 infection -- 7. Antiviral phytocompounds against animal-to-human transmittable SARS-CoV-2 -- 8. Plants-derived bioactive compounds as potential ACE-2 inhibitors against SARS-CoV-2 infection -- 9. Insights into in silico methods to explore plant bioactive substances in combating SARS-CoV-2 -- 10. Dietary plants, spices and fruits in curbing SARS-CoV-2 virulence -- 11. Therapeutic potential of selected medicinal plants for neurological disorders after the infection of COVID-19 -- 12. Glycyrrhizae Radix et Rhizoma (Gan Cao) for the management of COVID-19 -- 13. COVID-19-induced kidney disease: Ethnopharmacological intervention to ameliorate kidney damage and improve kidney function -- 14. Phytochemicals and nutraceuticals targeting SARS-CoV-2: An in silico analysis -- 15. Therapeutic and prophylactic effects of plant derivatives against SARS-CoV-2 -- 16. Therapeutic potential of essential oils against SARS-CoV-2 infection -- 17. Antiviral properties of South Indian plants against SARS-CoV-2 -- 18. Immune-boosting plants used in Turkish folk medicine and their potential against COVID-19 -- 19. A comparison study of medicinal plants used against SARS-CoV-2 and those recommended against malaria in Africa -- 20. Exploring the potential antiviral properties of Nigella sativa L. against SARS-CoV-2: Mechanisms and prospects -- . |
| Record Nr. | UNINA-9910746084103321 |
|
Chen Jen-Tsung
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Helicobacter pylori and Gastric Cancer [[electronic resource] /] / edited by Steffen Backert
| Helicobacter pylori and Gastric Cancer [[electronic resource] /] / edited by Steffen Backert |
| Autore | Backert Steffen |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (328 pages) |
| Disciplina | 616.9041 |
| Collana | Current Topics in Microbiology and Immunology |
| Soggetto topico |
Medical microbiology
Cancer Bacteria Diseases - Causes and theories of causation Medical Microbiology Cancer Biology Pathogenesis |
| ISBN | 3-031-47331-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Gastric stem cell biology and Helicobacter pylori infection -- Clinical pathogenesis and molecular mechanisms of gastric cancerogenesis -- Helicobacter pylori metabolism and mitochondrial dysfunction in gastric cancer development -- Immune biology and persistence of Helicobacter pylori in gastric diseases -- Pathogenomics of Helicobacter pylori infection -- Helicobacter pylori interactions with the microbiota and gastric cancer development -- Helicobacter pylori-induced host cell DNA damage and gastric carcinogenesis -- Gastric inflammation and oncogenic signal transduction networks by Helicobacter pylori -- Impact of Helicobacter pylori oncoprotein CagA and vacuolating cytotoxin VacA in gastric cancer -- Role of proteases in Helicobacter pylori infections and gastric diseases -- Clinical management of gastric cancer treatment regimes. |
| Record Nr. | UNINA-9910805569403321 |
|
Backert Steffen
|
||
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Insights into Avascular Necrosis of the Femoral Head : Learning for the Trainees and Professionals / / edited by Prasoon Kumar, Sameer Aggarwal, Vishal Kumar
| Insights into Avascular Necrosis of the Femoral Head : Learning for the Trainees and Professionals / / edited by Prasoon Kumar, Sameer Aggarwal, Vishal Kumar |
| Autore | Kumar Prasoon |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (201 pages) |
| Disciplina | 617.581 |
| Altri autori (Persone) |
AggarwalSameer
KumarVishal |
| Soggetto topico |
Orthopedics
Orthopedic surgery Epidemiology Diseases - Causes and theories of causation Orthopaedics Surgical Orthopedics Pathogenesis |
| ISBN | 981-9913-46-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Femoral Head- Anatomical Considerations -- Avascular Necrosis Of Hip- Historical Perspective -- Epidemiology And Risk Factors -- Etiology & Pathophysiology -- Clinical Features And Staging -- Avascular Necrosis Hip: How To Examine A Suspected Case -- AVN Hip: Radiology -- Treatment Principles An Overview -- Core Decompression -- Osteotomies For Osteonecrosis Hip -- Head Preservation Recent Advances -- Hip Arthrodesis Current Concepts -- Hip Arthroplasty.-Avascular Necrosis Of Hip Replace Or Resurface -- AVN Hip Bedside Case Presentation -- FAQs For Trainees -- MCQs. |
| Record Nr. | UNINA-9910735796303321 |
|
Kumar Prasoon
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nanosensors for Point-of-Care Diagnostics of Pathogenic Bacteria / / edited by Amitabha Acharya, Nitin Kumar Singhal
| Nanosensors for Point-of-Care Diagnostics of Pathogenic Bacteria / / edited by Amitabha Acharya, Nitin Kumar Singhal |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (184 pages) |
| Disciplina | 616.92075 |
| Soggetto topico |
Nanobiotechnology
Diseases—Causes and theories of causation Biochemical markers Pathogenesis Biomarkers |
| ISBN | 981-9912-18-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. The surface biomarkers present on the bacterial cell surface -- 2. Optical nanosensors and their integrated approaches for the detection of pathogens -- 3. Surface Plasmon Resonance (SPR) Based Nanosensors for the Detection of Pathogenic Bacteria -- 4. Enzyme-linked Immunosorbent Assay-based nanosensors for the detection of pathogenic bacteria -- 5. Nanosensors enabled microfluidic biosensors for the detection of pathogenic bacteria -- 6. Electrochemical/voltammetric/amperometric nanosensors for the detection of pathogenic bacteria -- 7. Quartz Crystal Microbalance (QCM) based nanosensors for the detection of pathogenic bacteria -- 8. Surface Enhanced Raman Spectroscopy (SERS) based nanosensor for the detection of pathogenic bacteria. |
| Record Nr. | UNINA-9910731478703321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases : Volume I: Liver, Skin, Thyroid, Rheumatic & Myopathic Diseases / / edited by Mitesh Kumar Dwivedi, N. Amaresan, E. Helen Kemp, Yehuda Shoenfeld
| Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases : Volume I: Liver, Skin, Thyroid, Rheumatic & Myopathic Diseases / / edited by Mitesh Kumar Dwivedi, N. Amaresan, E. Helen Kemp, Yehuda Shoenfeld |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (680 pages) |
| Disciplina | 616.978 |
| Soggetto topico |
Immunology
Diseases - Causes and theories of causation Autoimmunity Medicine - Research Biology - Research Pathogenesis Biomedical Research Malalties autoimmunitàries Ecologia microbiana Etiologia Terapèutica |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-19-1946-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I: OVERVIEW OF INFECTIOUS MICROORGANISMS & MICROBIOTA IN INDUCING AUTOIMMUNIT -- Chapter 1. The Concept of Infection Triggered autoimmunity -- Chapter 2. The interaction of gut microbiota with immune system and their effects on immune cell development and function -- Chapter 3. The Link between gut microbiota and autoimmune diseases -- Chapter 4. The factors influencing gut microbiota in autoimmune diseases -- PART II: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE LIVER DISEASES -- Chapter 5. Microorganisms in pathogenesis and management of Autoimmune hepatitis (AIH) -- Chapter 6. Microorganisms in pathogenesis and management of Primary Biliary Cholangitis -- Chapter 7. Microorganisms in pathogenesis and management of Primary biliary cholangitis -- PART III: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF SKIN AUTOIMMUNE DISEASES -- Chapter 8. Microorganisms in pathogenesis and management of Psoriasis -- Chapter 9. Microorganisms in pathogenesis and management of Vitiligo -- Chapter 10. Microorganisms in pathogenesis and management of Scleroderma (systemic sclerosis) -- Chapter 11. Microorganisms in pathogenesis and management of Atopic Dermatitis -- Chapter 12. Microorganisms in pathogenesis and management of Pemphigus Vulgaris -- Chapter 13. Microorganisms in pathogenesis and management of Bullous pemphigoid -- PART IV: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE THYROID DISEASES -- Chapter 14. Microorganisms in pathogenesis and management of Graves's Disease -- Chapter 15. Microorganisms in pathogenesis and management of Hashimoto's Thyroiditis -- PART V: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE RHEUMATIC DISEASES -- Chapter 16. Microorganisms in pathogenesis and management of Rheumatoid Arthritis (RA) -- Chapter 17. Microorganisms in pathogenesis and management of Spondyloarthritis -- Chapter 18. Microorganisms in pathogenesis and management of Ankylosing spondylitis (AS) -- Chapter 19. Microorganisms in pathogenesis and management of Psoriasis Arthritis (PsA) -- Chapter 20. Microorganisms in pathogenesis and management of Systemic Lupus Erythematosus (SLE) -- Chapter 21. Microorganisms in pathogenesis and management of Sjogren’s syndrome -- Chapter 22. Autoimmune Diseases Associated with Chikungunya Infection -- PART VI: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF IDIOPATHIC INFLAMMATORY MYOPATHIES -- Chapter 23. Microorganisms in pathogenesis and management of dermatomyositis (DM) and polymyositis (PM) -- Chapter 24. Microorganisms in pathogenesis and management of necrotizing autoimmune myopathy (NAM) and inclusion body myositis (IBM). |
| Record Nr. | UNINA-9910586576503321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Tuberculosis : Integrated Studies for a Complex Disease / / edited by Nima Rezaei
| Tuberculosis : Integrated Studies for a Complex Disease / / edited by Nima Rezaei |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (XXIV, 1116 p. 363 illus., 239 illus. in color.) |
| Disciplina |
610.72
616.995 |
| Collana | Integrated Science |
| Soggetto topico |
Medicine—Research
Biology—Research Clinical medicine—Research Epidemiology Diseases—Causes and theories of causation Biomedical Research Clinical Research Pathogenesis |
| ISBN | 3-031-15955-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Introduction on Tuberculosis: Integrated Studies for a Complex Disease -- 2. Global Tuberculosis Epidemiology -- 3. Heterogeneity in Tuberculosis -- 4. The Unequivocal Relationship between Tuberculosis and Tobacco: Integration of Two Maladies -- 5. Relationship between Pre-existing Cancer and Tuberculosis -- 6. Laboratory Diagnosis of Tuberculosis -- 7. The Role of Diagnostic Microdevices in the Fight Against Tuberculosis -- 8. Immunodiagnostics of Tuberculosis: Recent Discoveries -- 9. Role of Bronchoscopy in Diagnostics and Treatment of Tuberculosis -- 10. Diagnosis of Childhood Tuberculosis in Low- and Middle-income Countries -- 11. Pediatric Tuberculosis: Current Evidence for Laboratory Diagnosis -- 12. A Multidisciplinary Approach Towards Finding and Treating All Tuberculosis Patients -- 13. Chemotherapy for Drug-Susceptible Tuberculosis -- 14. The Pharmacokinetic and Pharmacodynamic Properties of Antitubercular Medications -- 15. Immune Approaches In Tuberculosis Treatment -- 16. Inhalation Therapy in Pulmonary Tuberculosis -- 17. Role of Micronutrients in Tuberculosis Management -- 18. Drug Resistance in Tuberculosis: Mechanisms, Diagnosis, New Responses, and the Need for An Integrated Approach -- 19. Resistance in Tuberculosis: Molecular Mechanisms and Modulation -- 20. Personalized Tuberculosis Care for Drug-Resistant Tuberculosis -- 21. Important Targets and Inhibitors of Mycobacterium Tuberculosis -- 22. P-type ATPases: A Relevant Component in Mycobacterium tuberculosis Viability -- 23. The Challenges of Antitubercular Drug Discovery -- 24. Exploring Decaprenylphosphoryl-β-D-ribose 2’-Epimerase 1 (DprE1): A Target for Anti-Tubercular Drugs -- 25. Energy Pathways in Mycobacterium Tuberculosis -- 26. Drug Discovery for Non-Tuberculous Mycobacteria: Recent Updates -- 27. Challenges for Contact Tracing and Tuberculosis Preventive Therapy Scale-up -- 28. Exploring Problematizations Underlying Tuberculosis Control Strategies: A Cross-Country Analysis of India and Kenya -- 29. Challenges in Prevention and Management of Tuberculosis -- 30. Tuberculosis in Contacts and Healthcare Workers -- 31. Tuberculosis Among People Who Use Drugs: Multilevel Considerations for Prevention, Diagnosis, and Treatment -- 32. Anti-Tumor Necrosis Factor-α Antagonists and Tuberculosis -- 33. Breast Tuberculosis -- 34. Central Nervous System Tuberculosis: Pathogenesis, Diagnosis, and Management -- 35. Pleural Tuberculosis -- 36. Ocular Tuberculosis -- 37. Ocular Tuberculosis: Biomarkers for Risk Stratification -- 38. Bone and Joint Tuberculosis -- 39. Abdominal Tuberculosis: Pathogenesis, Clinical Features, and Diagnosis -- 40. Bovine Tuberculosis at The Interface of Cattle, Wildlife, and Humans -- 41. Evolution and Molecular Characteristics of Mycobacterium Tuberculosis and Mycobacterium Bovis -- 42. Animal Tuberculosis: Gross Lesions and Anatomopathological Diagnosis -- 43. Estimation of Microbial Mutation Rates in Tuberculosis Research -- 44. The Role of Epigenetics in the Development of Anti-Tuberculosis Drug Resistance -- 45. Multiomics Integration of Tuberculosis Pathogenesis -- 46. Lung Microbiome in Tuberculosis -- 47. The Correlation of Microbiota and Host Epigenome in Tuberculosis -- 48. The Pathogenesis and Progression of Sarcoidosis from The Standpoint of Tuberculosis -- 49. Tuberculosis: A Historical and Global Bioethical Perspective -- 50. The Problem of Tuberculosis: Myths, Stigma, and Mimics -- 51. Tuberculosis: Integrated Studies for a Complex Disease 2050. |
| Record Nr. | UNINA-9910686786203321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
